Finally, a solution to address specialty pharmacy costs.

Ethicos Health offers a clinical guideline administration platform for specialty pharmacy.

To date, there has been no independent, transparent, clinically-validated platform to manage specialty pharmacy and complex therapy costs.

Until Now.

Specialty pharmacy medications, including GLP-1s, can be life-changing therapies at the forefront of medicine.

They can also be very expensive, often ineffective and potentially harmful.

Very expensive

In 2023, the average cost of specialty pharmacy medication was
$84,000 / course.

In 2027, with the introduction of new cell and gene therapies, the cost will grow to 
$2,500,000 / course.

Often ineffective

Many specialty medications have been pulled from the market due to ineffectiveness.

Others continue to be prescribed even though the drug is not effective as measured by intended clinical endpoints.

Potentially harmful

Up to 40% of patients who are on 7-12 medications are more likely to be prescribed a specialty medication inappropriately.

 

Introducing

The Ethicos Health Clinical Guideline Administration Platform

The first independent, transparent, clinically-validated platform to manage specialty pharmacy and complex therapy costs.

  • Enables better and safer care for patients.

  • Reduces costs for plan sponsors and their members.

  • Navigates clinical guidelines for physicians to provide the best patient care.

  • Provides fiduciary compliance and oversight for specialty pharmacy spend.

Let us power your specialty pharmacy management program

Our AI-enabled platform provides clarity and transparency to the field of specialty pharmaceutical and complex therapies to manage your specialty pharmacy program in a high-quality and cost-effective manner.